BDNF
Articles tagged with “BDNF”
Biomarkers for Predicting Ketamine Treatment Response
A review of emerging biological markers that may predict which patients will respond to ketamine therapy, including inflammatory markers, neuroimaging signatures, genetic polymorphisms, and electrophysiological features.
BDNF Signaling and Ketamine's Antidepressant Action
A detailed examination of how ketamine activates brain-derived neurotrophic factor signaling, TrkB receptor pathways, and the mTOR cascade to produce rapid antidepressant effects. Covers molecular mechanisms, clinical evidence, and implications for personalized treatment.
Ketamine, Neuroplasticity, and Brain-Derived Neurotrophic Factor
An exploration of the molecular and cellular mechanisms by which low-dose ketamine promotes neuroplasticity. This article reviews the role of BDNF signaling, mTOR pathway activation, and synaptogenesis in mediating ketamine's antidepressant effects.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.